Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson's animal models

F Jahansooz, BE Hosseinzade, AH Zarmi… - Therapeutic …, 2020 - Future Science
Aim: Parkinson's disease (PD) is a neurological disorder resulting from decreased
dopamine (DA) secretion in the brain, which reflects impaired motor function. Thus, a drug …
被引用次数：17 相关文章

Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson's animal models.

F Jahansooz, BE Hosseinzade, AH Zarmi… - Therapeutic …, 2020 - europepmc.org
Aim: Parkinson's disease (PD) is a neurological disorder resulting from decreased
dopamine (DA) secretion in the brain, which reflects impaired motor function. Thus, a drug …

Dopamine-loaded Poly (butyl cyanoacrylate) Nanoparticles Reverse Behavioral Deficits in Parkinson's Animal Models

F Jahansooz, BE Hosseinzade, AH Zarmi… - Therapeutic …, 2020 - Taylor & Francis
Aim: Parkinson's disease (PD) is a neurological disorder resulting from decreased
dopamine (DA) secretion in the brain, which reflects impaired motor function. Thus, a drug …

Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson's animal models

F Jahansooz, BE Hosseinzade… - Therapeutic …, 2020 - pubmed.ncbi.nlm.nih.gov
Aim: Parkinson's disease (PD) is a neurological disorder resulting from decreased
dopamine (DA) secretion in the brain, which reflects impaired motor function. Thus, a drug …